Marco Valgimigli

140.2k total citations · 13 hit papers
526 papers, 29.6k citations indexed

About

Marco Valgimigli is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Marco Valgimigli has authored 526 papers receiving a total of 29.6k indexed citations (citations by other indexed papers that have themselves been cited), including 430 papers in Cardiology and Cardiovascular Medicine, 301 papers in Surgery and 108 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Marco Valgimigli's work include Coronary Interventions and Diagnostics (263 papers), Antiplatelet Therapy and Cardiovascular Diseases (227 papers) and Acute Myocardial Infarction Research (220 papers). Marco Valgimigli is often cited by papers focused on Coronary Interventions and Diagnostics (263 papers), Antiplatelet Therapy and Cardiovascular Diseases (227 papers) and Acute Myocardial Infarction Research (220 papers). Marco Valgimigli collaborates with scholars based in Italy, Switzerland and Netherlands. Marco Valgimigli's co-authors include Stephan Windecker, Pascal Vranckx, Julinda Mehilli, Marco Roffi, Felicita Andreotti, Robert F. Storey, Carlo Patrono, Christian Mueller, Michael A. Borger and Derek P. Chew and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Marco Valgimigli

500 papers receiving 28.9k citations

Hit Papers

2015 ESC Guidelines for the management of acute co... 2007 2026 2013 2019 2015 2011 2007 2017 2012 1000 2.0k 3.0k 4.0k 5.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
    2015 5.1k citations Marco Roffi, Carlo Patrono et al. European Heart Journal profile →
  2. Standardized Bleeding Definitions for Cardiovascular Clinical Trials
    2011 2.9k citations Roxana Mehran, Deepak L. Bhatt et al. Circulation profile →
  3. Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents
    2007 707 citations Julinda Mehilli, Marco Valgimigli et al. profile →
  4. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
    2017 659 citations Francesco Costa, Stefan James et al. profile →
  5. Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting
    2012 441 citations Marco Valgimigli, Gianluca Campo et al. Circulation profile →
  6. Linee guida ESC 2015 per il trattamento delle sindromi coronariche acute nei pazienti senza sopraslivellamento persistente del tratto ST alla presentazione. Task Force per il Trattamento delle Sindromi Coronariche Acute nei Pazienti senza Sopraslivellamento Persistente del Tratto ST alla Presentazione della Società Europea di Cardiologia (ESC)
    2016 413 citations Marco Roffi, Carlo Patrono et al. Giornale italiano di cardiologia profile →
  7. Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial
    2019 383 citations Pascal Vranckx, Marco Valgimigli et al. profile →
  8. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
    2018 371 citations Stefan James, Marco Roffi et al. profile →
  9. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
    2017 332 citations Stefan James, Marco Roffi et al. profile →
  10. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
    2015 329 citations Marco Roffi, Carlo Patrono et al. profile →
  11. Long-Term Safety of Drug-Eluting and Bare-Metal Stents
    2015 326 citations Tullio Palmerini, Marco Valgimigli et al. Journal of the American College of Cardiology profile →
  12. Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease
    2016 305 citations Giuseppe Ferrante, Stephan Windecker et al. profile →
  13. ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy
    2018 221 citations Davide Capodanno, Marco Valgimigli et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Valgimigli Italy 80 23.4k 15.2k 7.0k 3.9k 3.7k 526 29.6k
Dean J. Kereiakes United States 86 19.8k 0.8× 19.0k 1.2× 6.6k 0.9× 4.8k 1.3× 2.8k 0.8× 502 28.4k
George Dangas United States 88 19.0k 0.8× 16.8k 1.1× 8.0k 1.1× 6.8k 1.8× 3.2k 0.9× 669 29.6k
Julinda Mehilli Germany 80 21.5k 0.9× 15.1k 1.0× 7.2k 1.0× 4.3k 1.1× 2.5k 0.7× 374 27.3k
Debabrata Mukherjee United States 61 21.0k 0.9× 11.6k 0.8× 6.6k 0.9× 3.5k 0.9× 3.1k 0.9× 466 29.8k
Manesh R. Patel United States 79 22.4k 1.0× 9.4k 0.6× 8.9k 1.3× 3.2k 0.8× 6.5k 1.8× 545 30.9k
Stefan James Sweden 76 21.6k 0.9× 11.5k 0.8× 4.2k 0.6× 1.9k 0.5× 4.1k 1.1× 496 26.7k
Neal S. Kleiman United States 74 16.4k 0.7× 10.4k 0.7× 4.2k 0.6× 2.2k 0.6× 3.6k 1.0× 454 21.4k
Adnan Kastrati Germany 102 26.9k 1.1× 24.7k 1.6× 10.1k 1.4× 6.9k 1.8× 3.5k 1.0× 782 38.9k
Gilles Montalescot France 80 23.1k 1.0× 12.3k 0.8× 3.3k 0.5× 2.7k 0.7× 5.8k 1.6× 553 28.8k
Peter B. Berger United States 76 16.2k 0.7× 10.5k 0.7× 3.6k 0.5× 2.5k 0.7× 3.5k 1.0× 360 22.6k

Countries citing papers authored by Marco Valgimigli

Since Specialization
Citations

This map shows the geographic impact of Marco Valgimigli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Valgimigli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Valgimigli more than expected).

Fields of papers citing papers by Marco Valgimigli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Valgimigli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Valgimigli. The network helps show where Marco Valgimigli may publish in the future.

Co-authorship network of co-authors of Marco Valgimigli

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Valgimigli. A scholar is included among the top collaborators of Marco Valgimigli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Valgimigli. Marco Valgimigli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giacoppo, Daniele, Felice Gragnano, Hirotoshi Watanabe, et al.. (2025). P2Y12inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials. BMJ. 389. e082561–e082561. 10 indexed citations
2.
Valgimigli, Marco, et al.. (2025). Relevance of High Bleeding Risk and Postdischarge Bleeding in Patients Undergoing Percutaneous Coronary Intervention. Mayo Clinic Proceedings. 100(2). 304–331.
3.
Moreno, Raúl, Rüdiger Smolnik, Luis Nombela‐Franco, et al.. (2024). Outcomes after TAVI in patients with atrial fibrillation and a history of recent PCI: Results from the ENVISAGE-TAVI AF trial. Clinical Research in Cardiology. 114(3). 313–322. 1 indexed citations
4.
Bergamaschi, Luca, Antonio Landi, Niccolò Maurizi, et al.. (2024). Acute Response of the Noninfarcted Myocardium and Surrounding Tissue Assessed by T2 Mapping After STEMI. JACC. Cardiovascular imaging. 17(6). 610–621. 24 indexed citations
5.
Stone, Gregg W., Marco Valgimigli, David Erlinge, et al.. (2024). Bivalirudin vs Heparin Anticoagulation in STEMI. Journal of the American College of Cardiology. 84(16). 1512–1524. 6 indexed citations
6.
Licordari, Roberto, Francesco Costa, Victoria Garcia-Ruiz, et al.. (2024). The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome. Journal of Clinical Medicine. 13(7). 1885–1885. 2 indexed citations
7.
Bergamaschi, Luca, Niccolò Maurizi, Dimitri Arangalage, et al.. (2023). Increased hepatic T1 values are correlated with right ventricular involvement and congestion after ST-segment elevation myocardial infarction. European Heart Journal - Cardiovascular Imaging. 24(Supplement_1). 1 indexed citations
8.
Yin, Dean R.P.P. Chan Pin, Marco Valgimigli, Stephan Windecker, et al.. (2020). Patient-tailored antithrombotic therapy following percutaneous coronary intervention. European Heart Journal. 42(10). 1038–1046. 22 indexed citations
9.
Seo, Michael, Ian R. White, Toshi A. Furukawa, et al.. (2020). Comparing methods for estimating patient‐specific treatment effects in individual patient data meta‐analysis. Statistics in Medicine. 40(6). 1553–1573. 21 indexed citations
10.
Gargiulo, Giuseppe & Marco Valgimigli. (2016). Terapia antitrombotica nei pazienti sottoposti a impianto transcatetere di valvola aortica. Giornale italiano di cardiologia. 17(6). 4S–10.
11.
Lee, Seung‐Yul, Myeong‐Ki Hong, Dong‐Ho Shin, et al.. (2016). Clinical outcomes of dual antiplatelet therapy after implantation of drug-eluting stents in patients with different cardiovascular risk factors. Clinical Research in Cardiology. 106(3). 165–173. 12 indexed citations
12.
13.
Roffi, Marco, Carlo Patrono, Jean‐Philippe Collet, et al.. (2015). 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal. 37(3). 267–315. 5104 indexed citations breakdown →
14.
Meloni, Marco, Daniela Cesselli, Andrea Caporali, et al.. (2015). Cardiac Nerve Growth Factor Overexpression Induces Bone Marrow–derived Progenitor Cells Mobilization and Homing to the Infarcted Heart. Molecular Therapy. 23(12). 1854–1866. 14 indexed citations
15.
16.
Valgimigli, Marco, Gianluca Campo, Monia Monti, et al.. (2012). Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting. Circulation. 125(16). 2015–2026. 441 indexed citations breakdown →
17.
Briguori, Carlo, Gabriella Visconti, Amelia Focaccio, et al.. (2011). Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II). Circulation. 124(11). 1260–1269. 158 indexed citations
18.
19.
Brar, Somjot, Jurriën M. ten Berg, Rossella Marcucci, et al.. (2011). Impact of Platelet Reactivity on Clinical Outcomes After Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 58(19). 1945–1954. 327 indexed citations
20.
Ferrari, Roberto, et al.. (2000). CARDIOPROTECTION WITH ACE INHIBITORS: NON-ANGIOTENSIN II-RELATED MECHANISMS. Institutional Research Information System University of Ferrara (University of Ferrara). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dean J. Kereiakes Breakdown of academic impact, for papers by George Dangas Breakdown of academic impact, for papers by Julinda Mehilli Breakdown of academic impact, for papers by Debabrata Mukherjee Breakdown of academic impact, for papers by Manesh R. Patel Breakdown of academic impact, for papers by Stefan James Breakdown of academic impact, for papers by Neal S. Kleiman Breakdown of academic impact, for papers by Adnan Kastrati Breakdown of academic impact, for papers by Gilles Montalescot Breakdown of academic impact, for papers by Peter B. Berger
Rankless by CCL
2026